ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,908.49
-2.35%
US Tech 100
20,740.40
-3.23%
Dow Jones
42,531.36
-2.11%
Brent Oil
72.65
-0.62%
Bitcoin
101,603.83
-4.28%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Assembly Biosciences Inc (ASMB)

  7. Assembly Biosciences Inc (ASMB) News

ASMB

Assembly Biosciences (ASMB)

Assembly Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ASMB
DateTimeSourceHeadlineSymbolCompany
12/13/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
11/26/20249:15AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
11/19/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
11/14/20243:22PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:ASMBAssembly Biosciences Inc
11/07/20244:50PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
11/07/20244:42PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ASMBAssembly Biosciences Inc
11/07/20244:24PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
11/07/20244:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
11/07/20244:05PMGlobeNewswire Inc.Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent UpdatesNASDAQ:ASMBAssembly Biosciences Inc
10/09/20249:15AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
10/04/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
10/04/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
09/23/20248:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
09/23/20248:00AMGlobeNewswire Inc.Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366NASDAQ:ASMBAssembly Biosciences Inc
08/08/20244:31PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ASMBAssembly Biosciences Inc
08/08/20244:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
08/08/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
08/08/20244:05PMGlobeNewswire Inc.Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent UpdatesNASDAQ:ASMBAssembly Biosciences Inc
08/05/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
08/05/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
07/15/20248:00AMGlobeNewswire Inc.Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus WorkshopNASDAQ:ASMBAssembly Biosciences Inc
07/08/202410:48AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
06/18/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
06/18/20244:06PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ASMBAssembly Biosciences Inc
06/18/20248:00AMGlobeNewswire Inc.Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus InfectionNASDAQ:ASMBAssembly Biosciences Inc
06/17/20248:00AMGlobeNewswire Inc.Assembly Biosciences Announces $12.6 Million in Equity FinancingsNASDAQ:ASMBAssembly Biosciences Inc
06/10/20248:00AMGlobeNewswire Inc.Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366NASDAQ:ASMBAssembly Biosciences Inc
06/05/20248:00AMGlobeNewswire Inc.Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024NASDAQ:ASMBAssembly Biosciences Inc
06/03/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
05/30/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ASMB

Your Recent History

NASDAQ
NUKK
Nukkleus
AMEX
KULR
KULR Technology
USOTC
TPTW
TPT Global Tech (CE)
AMEX
SPY
SPDR S&P 500
USOTC
ICTY
Eyecity Com (PK)
NASDAQ
TNXP
Tonix Pharmaceuticals
USOTC
RDAR
Raadr (PK)
USOTC
GTCH
GBT Technologies (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
ZHUD
Zhuding (PK)
NASDAQ
NXPL
NextPlat
USOTC
QSEP
QS Energy (PK)
USOTC
RDGL
Vivos (QB)
NASDAQ
NVDA
NVIDIA
USOTC
SPZI
Spooz (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads